ADVERTISEMENT

Sweden

Nordic Countries Launch ‘English-Only’ Packaging Pilot To Tackle Medicine Shortages

Drug companies are being invited to participate in a new pilot project that the five Nordic countries will run to see if they can improve the availability of certain critical products that are used in hospitals.

Nordic Medtech Experts Urge More Collaboration On Health Technology Assessments

European cross-country HTA collaborations have much to learn from each other to keep prices from rising unfairly, Nordic health technology assessment experts say, adding that talks on collaboration are also ongoing with HTA bodies outside the continent.

Cross-Country HTA Collaboration To Focus On Health Economics & RWE

European cross-country HTA collaborations have much to learn from each other to keep drug prices from rising unfairly, Nordic health technology assessment experts say, adding that talks on collaboration are also ongoing with HTA bodies outside the continent.

Nordic HTA Body Tells Pharma Users: ‘Feel the Fear And Do It Anyway’

It is time for companies to take part in cross-country health technology assessments and stop only asking “what’s in it for me?”

Nordic HTA Collaboration: Feel The Fear And Do It Anyway

It is time for companies to take part in cross-country health technology assessments and stop asking “what’s in it for me?”

Navamedic Benefits From Eroxon Launch In Nordics

OTC erectile dysfunction treatment Eroxon has made it to the Nordics through local distributor Navamedic, which has reported strong consumer uptake.

Xbrane Reveals Urgency To Find A Partner For One Of Two Biosimilars By October

Cash is king for fledgling biosimilar companies. Xbrane Biopharma has revealed just how close it is to the edge after Biogen unexpectedly pulled the plug on a key licensing deal, but the company is maintaining optimism.

UK Follows EU’s Lead In Scrutinizing Ashwagandha Safety In Supplements

UK regulator the Food Standards Agency intends to assess the risks associated with consuming supplements containing ashwagandha and to determine whether a safe level of the herb can be established. The launch of the consultation follows warnings from regulators across Europe about the safety of ashwagandha, with its consumption linked to a number of adverse health effects.

Xbrane Inching Closer To Cimzia Biosimilar Trials With Batch Production

Sweden’s Xbrane Biopharma has delivered updates for two of its more long-term projects, including a proposed biosimilar to Bristol Myers Squibb’s Opdivo for which it is actively seeking a partner.

Another Funding Win For Chiesi In Europe As Scotland OKs Elfabrio

Scotland’s health technology assessment body has agreed to reimburse Chiesi’s Elfabrio for Fabry disease, mirroring the decision from several other European countries – however, France turned down the rare disease drug, while Germany questioned its benefit.